Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 2/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | AGTR2 | P50052 | 4/20 | 0.33 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | STS | P08842 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | CCR3 | P51677 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1373775 | 0.90 | ALDH1A1 (0.41) | NR1H2NR1H3CYP1A2POLBCYP3A4 | |
| SCHEMBL24645440 | 0.81 | ALDH1A1 (0.40) | NR1H2NR1H3CYP1A2POLBCYP3A4 | |
| SCHEMBL1372326 | 0.81 | NR1H2 (0.40) | NR1H2NR1H3CYP1A2POLBCYP3A4 | |
| SCHEMBL2173029 | 0.81 | NR1H2 (0.40) | NR1H2NR1H3CYP1A2POLBCYP3A4 | |
| SCHEMBL1371619 | 0.81 | CCR3 (0.43) | NR1H2NR1H3CYP3A4AGTR2CCR3 | |
| SCHEMBL29036351 | 0.81 | CCR3 (0.43) | NR1H2NR1H3CYP3A4AGTR2CCR3 | |
| SCHEMBL2171252 | 0.81 | CCR3 (0.43) | NR1H2NR1H3CYP3A4AGTR2CCR3 | |
| SCHEMBL2170427 | 0.80 | CYP1A2 (0.40) | NR1H2NR1H3CYP1A2POLBCYP3A4 | |
| SCHEMBL1374880 | 0.80 | CYP1A2 (0.40) | NR1H2NR1H3CYP1A2POLBCYP3A4 | |
| SCHEMBL1375762 | 0.80 | ALDH1A1 (0.42) | CYP1A2CYP3A4CYP2C19ALDH1A1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791102-B2 | Acetanilide sphingosine-1-phosphate receptor antagonists | EXELIXIS, INC. (US) | 2014-07-29 | — | — | US | disclosed |
| US-20110288076-A1 | Sphingosine-1-Phosphate Receptor Antagonists | EXELIXIS, INC. (US) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288076-A1 | Sphingosine-1-Phosphate Receptor Antagonists | S1PR1, S1PR2, S1PR3 | NR1H2 253/4885NR1H3 287/4885CYP1A2 4844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.